“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

Aimee Hoyt Biography and Net Worth

SVP of Illumina

Aimee L. Hoyt is the Senior Vice President and Chief People Officer of Illumina, Inc, effective January 8, 2018. Ms. Hoyt has held senior positions at some of the world's best-known technology companies including Hewlett-Packard, Cisco and Sun Microsystems. Most recently, she was the Chief Human Resources Officer at Rackspace, a leading managed cloud computing company, in San Antonio, Texas. She led the HR team and was responsible for helping build, align and develop high-performing global teams. During her tenure, Rackspace was recognized as one of Fortune's 100 Best Companies to Work For, Top 30 Best Places in Tech and Great Places to Work for Millennials. Ms. Hoyt earned a master's in human resource development from the Rochester Institute of Technology.

What is Aimee L. Hoyt's net worth?: The estimated net worth of Aimee L. Hoyt is at least $1.01 million as of November 7th, 2023. Ms. Hoyt owns 8,314 shares of Illumina stock worth more than $1,006,410 as of April 26th. This net worth approximation does not reflect any other assets that Ms. Hoyt may own. Learn More about Aimee L. Hoyt's net worth.
How do I contact Aimee L. Hoyt?: The corporate mailing address for Ms. Hoyt and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected]. Learn More on Aimee L. Hoyt's contact information.
Has Aimee L. Hoyt been buying or selling shares of Illumina?: Aimee L. Hoyt has not been actively trading shares of Illumina during the last quarter. Most recently, Aimee L. Hoyt sold 315 shares of the business's stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $112.84, for a transaction totalling $35,544.60. Following the completion of the sale, the senior vice president now directly owns 8,314 shares of the company's stock, valued at $938,151.76. Learn More on Aimee L. Hoyt's trading history.
Who are Illumina's active insiders?: Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.
Are insiders buying or selling shares of Illumina?: In the last year, Illumina insiders bought shares 1 times. They purchased a total of 7,330 shares worth more than $991,675.70. In the last year, insiders at the life sciences company sold shares 4 times. They sold a total of 1,815 shares worth more than $314,104.60. The most recent insider tranaction occured on February, 22nd when CEO Jacob Thaysen bought 7,330 shares worth more than $991,675.70. Insiders at Illumina own 0.2% of the company. Learn More about insider trades at Illumina.
Information on this page was last updated on 2/22/2024.

Aimee L. Hoyt Insider Trading History at Illumina

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/7/2023	Sell	315	$112.84	$35,544.60	8,314
3/1/2023	Sell	3,917	$199.06	$779,718.02	2,881
1/9/2023	Sell	871	$205.57	$179,051.47	2,796
4/12/2022	Sell	2,474	$350.51	$867,161.74	5,342
6/24/2021	Sell	500	$475.00	$237,500.00
4/5/2021	Sell	1,000	$386.03	$386,030.00
1/11/2021	Sell	271	$379.65	$102,885.15	2,630
12/14/2020	Sell	354	$345.00	$122,130.00	2,744
11/6/2020	Sell	215	$310.10	$66,671.50	3,313
6/8/2020	Sell	191	$350.94	$67,029.54	3,498
3/5/2020	Sell	417	$273.95	$114,237.15	3,689
2/26/2019	Sell	298	$304.63	$90,779.74	2,297

Aimee L. Hoyt Buying and Selling Activity at Illumina

Illumina Company Overview

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Today's Range

Now: $121.05

$116.91

$121.97

50 Day Range

MA: $131.94

$116.69

$143.41

2 Week Range

Now: $121.05

$89.00

$217.60

Volume

962,067 shs

Average Volume

1,467,962 shs

Market Capitalization

$19.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19